1-3 of 3
Martin Wehling, Prof., Dr.
Close
Save search
Sort by
Journal Articles

Comparison of Cost-Effectiveness of Anticoagulation with Dabigatran, Rivaroxaban and Apixaban in Patients with Non-Valvular Atrial Fibrillation Across Countries

Free
Martin Krejczy, Job Harenberg, Prof., Dr., Svetlana Marx, Konrad Obermann, Prof., Dr., Martin Wehling, Prof., Dr.
Journal: Blood
Blood (2012) 120 (21): 1164.
https://doi.org/10.1182/blood.V120.21.1164.1164
Published: 2012
Journal Articles

Cluster Analysis Followed by Network Meta-Analysis to Compare Efficacy and Safety of Dabigatran, Rivaroxaban and Apixaban After Elective Total Knee and Hip Replacement Surgery

Free
Job Harenberg, Prof., Dr., Svetlana Marx, Shabnam Zolfaghari, Christel Weiss, Dr., Martin Wehling, Prof., Dr., Astrid Schulze, Dr., Ola E Dahl, MD
Journal: Blood
Blood (2012) 120 (21): 3409.
https://doi.org/10.1182/blood.V120.21.3409.3409
Published: 2012
Journal Articles

Indirect Comparisons of the New Oral Anticoagulants in Patients with Non-Valvular Atrial Fibrillation

Free
Shabnam Zolfaghari, Jr., M.Sc., Job Harenberg, Prof., Dr., Svetlana Marx, Martin Wehling, Prof., Dr.
Journal: Blood
Blood (2012) 120 (21): 4363.
https://doi.org/10.1182/blood.V120.21.4363.4363
Published: 2012